Ventas (NYSE:VTR) Releases FY 2026 Earnings Guidance

Ventas (NYSE:VTR) updated its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 3.820-3.890 for the period, compared to the consensus EPS estimate of 3.880. The company issued revenue guidance of -.

Ventas Stock Performance

Shares of VTR opened at $83.42 on Tuesday. Ventas has a 12 month low of $61.76 and a 12 month high of $91.06. The stock has a fifty day moving average price of $85.15 and a 200-day moving average price of $82.54. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The firm has a market cap of $40.56 billion, a PE ratio of 151.67, a P/E/G ratio of 1.82 and a beta of 0.71.

Ventas (NYSE:VTR) last announced its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter last year, the firm earned $0.84 earnings per share. The firm’s quarterly revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities research analysts predict that Ventas will post 3.88 earnings per share for the current fiscal year.

Ventas Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be paid a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Ventas’s dividend payout ratio (DPR) is 378.18%.

Analysts Set New Price Targets

A number of research analysts have issued reports on VTR shares. KeyCorp upped their price target on shares of Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Scotiabank boosted their target price on shares of Ventas from $93.00 to $95.00 and gave the company a “sector perform” rating in a research report on Thursday, May 21st. Citigroup upped their price target on shares of Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a report on Friday, May 1st. Mizuho set a $98.00 price objective on Ventas in a research note on Friday, May 22nd. Finally, Royal Bank Of Canada boosted their price objective on Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a report on Monday, May 4th. Fifteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $95.47.

Insiders Place Their Bets

In other news, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the sale, the director owned 28,349 shares in the company, valued at $2,557,079.80. This trade represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the business’s stock in a transaction dated Wednesday, June 3rd. The shares were bought at an average cost of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.53% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Ventas

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Prosperity Bancshares Inc purchased a new position in shares of Ventas during the 4th quarter worth $101,000. Kovack Advisors Inc. purchased a new stake in shares of Ventas in the fourth quarter valued at about $201,000. Larson Financial Group LLC grew its holdings in shares of Ventas by 320.0% in the third quarter. Larson Financial Group LLC now owns 1,739 shares of the real estate investment trust’s stock valued at $122,000 after purchasing an additional 1,325 shares during the period. Towarzystwo Funduszy Inwestycyjnych PZU SA increased its position in Ventas by 15.3% during the third quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA now owns 2,330 shares of the real estate investment trust’s stock worth $163,000 after purchasing an additional 310 shares during the last quarter. Finally, Brown Brothers Harriman & Co. increased its holdings in shares of Ventas by 202.7% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 1,550 shares of the real estate investment trust’s stock worth $108,000 after buying an additional 1,038 shares during the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.